CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.13
-0.69 (-6.38%)
At close: Feb 21, 2025, 4:00 PM
10.20
+0.07 (0.69%)
After-hours: Feb 21, 2025, 7:08 PM EST
CorMedix Market Cap
CorMedix has a market cap or net worth of $614.66 million as of February 21, 2025. Its market cap has increased by 278.95% in one year.
Market Cap
614.66M
Enterprise Value
569.19M
1-Year Change
278.95%
Ranking
Category
Stock Price
$10.13
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $614.66M, an increase of 1,697.25%. That is a compound annual growth rate of 21.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 614.70M | 25.07% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.46B |
| UnitedHealth Group | 467.12B |
| Johnson & Johnson | 380.11B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.87B |
| Abbott Laboratories | 228.53B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.32B |